Mucormycosis-associated fungal infections in patients with haematologic malignancies

International Journal of Clinical Practice

Volumn 63, Issue 1, 2009, Pages 134-139

  Kara, I O ^a   Tasova, Y ^a   Uguz, A ^a   Sahin, B ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; BETA LACTAM;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APLASIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION RISK; KIDNEY DYSFUNCTION; LUNG INFECTION; MALE; MORTALITY; MUCORMYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHODGKIN LYMPHOMA; PARANASAL SINUS; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG DISEASES, FUNGAL; MALE; MUCORMYCOSIS; MULTIVARIATE ANALYSIS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 57649230138     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01145.x     Document Type: Article

References (39)

1. Herbrecht R, Letscher-Bru V, Bowden RA et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001 20 : 460 6.
2. Sugar AM. Agents of mucormycosis and related species. In : Mandell GI, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th edn. New York : Churchill Livingstone, 2000 : 2685 95.
3. Chimelli L, Mahler-Araujo MB. Fungal infections. Brain Pathol 1997 7 : 613 27.
4. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston VI. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000 30 : 851 6.
5. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukaemia and lymphoma. Ann Intern Med 1972 77 : 871 9.
6. Nosari A, Oreste P, Montillo M et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica 2000 85 : 1068 71.
7. Peterson KL, Wang M, Canalis RF, Abemayour E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Larynposcope 1997 107 : 855 62.
8. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999 159 : 1301 19.
9. Pagano L, Offidani M, Fianchi L, Nosari A, Candonni A, Piccardi M et al. Mucormycosis in hematologic patients. Haematologica 2004 89 : 207 14.
10. Pagano L, Ricci P, Nosari A et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995 89 : 500 5.
11. Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993 11 : 383 8.
12. St-Germain G, Robert A, Ishak M, Tremblay C, Claveau S. Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clin Infect Dis 1993 16 : 640 5.
13. Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994 57 : 1044 50.
14. Parfrey NA. Improved diagnosis and prognosis of mucormycois. A clinicopathologic study of 33 cases. Medicine 1986 65 : 113 23.
15. Dykhuizen RS, Kerr KN, Soutar RL. Air crescent sign and fatal haemoptysis in pulmonary mucormycosis. Scand J Infect Dis 1994 26 : 498 501.
16. Tonso A, Ricci P, Cenacchi A et al. Invasive infections by fylamentous mycetes in adult patients with hematological neoplastic diseases (polycentric and retrospective study of 162 cases). Haematologica 1993 78 (Suppl.4 24.
17. Fingeroth JD, Roth RS, Talcott JA, Rinaldi MG. Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia. Clin Infect Dis 1994 19 : 135 7.
18. Lueg EA, Ballagh RH, Forte V. Analysis of the recent cluster of invasive fungal sinusitis at the Toronto Hospital for Sick Children. J Otolaryngol 1996 25 : 366 70.
19. Chinn RY, Diamond RD. Generation of chemotacticfactors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982 38 : 1123 9.
20. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000 13 : 236 301.
21. Funada H, Matsuda T. Pulmonary mucormycosis in a hematology ward. Intern Med 1996 35 : 540 4.
22. Maertens J, Demuynck H, Verbeken EK et al. Mucormycosis in allogenic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999 24 : 307 12.
23. McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF Jr. Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol 1997 168 : 1541 8.
24. Glazer M, Nusair S, Breuer R, Lafair J, Sherman Y, Berkman N. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 2000 117 : 279 82.
25. Bigby TD, Serota ML, Tierney LM Jr., Matthay MA. Clinical spectrum of pulmonary mucormycosis. Chest 1986 89 : 435 9.
26. Ma B, Seymour JF, Januszewicz H, Slavin MA. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia. Role of liposomal amphotericin B and GM-CSF. Leuk Lymphoma 2001 42 : 1393 9.
27. Morduchowicz G, Shmueli D, Shapira Z et al. Rhinocerebral mucormycosis in renal transplant recipients: report of three cases and review of the literature. Rev Infect Dis 1986 8 : 441 6.
28. Gomez-Lopez A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. In vitro susceptibilities of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole, and voriconazole. J Antimicrob Chemother 2001 48 : 919 21.
29. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003 36 : 1445 57.
30. Roy V, Ali LI, Carter TH, Selby GB. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versushost disease. J Infect 2000 41 : 273 5.
31. Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 2003 20 : 201 6.
32. Kocak R, Tetiker T, Kocak M, Baslamisli F, Zorludemir S, Gonlusen G. Fluconazole in the treatment of three cases of mucormycosis. Eur J Clin Microbiol Infect Dis 1995 14 : 559 61.
33. Mosquera J, Warn PA, Rodriguez-Tudela JL, Denning DW. Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole. J Antimicrob Chemother 2001 48 : 583 6.
34. Mendoza-Ayala R, Tapia R, Salathe M. Spontaneously resolving pulmonary mucormycosis. Clin Infect Dis 1999 29 : 1335 6.
35. Odds FC, Van Gerven F, Espinel-Ingroff A et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998 42 : 282 8.
36. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002 46 : 1581 2.
37. Pfaller MA, Messer SA, Hollis RJ, Jones RN, the Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from sentry antimicrobial surveillence program, 2000. Antimicrob Agents Chemother 2002 46 : 1032 7.
38. Sugar AM, Liu XP. Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles. Antimicrob Agents Chemother 2000 44 : 2004 6 AM, Arango M, Fernandez D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 2003 36 : 1488 91.
39. Walsh TH, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M et al. Safety, tolerance, and pharmacokinetics of highdose liposomal amphotericin B (AmBisome) in patients infected with aspergillus species and other filamentous fungi: maximum tolerated dose study. Agents Chemother 2001 15 : 3487 96.